Tenofovir Alafenamide Fumarate Information
| Product Name: | Tenofovir Alafenamide Fumarate |
| Synonyms: | L-Alanine,N-[(S)-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-,1-methylethylester,(2E)-2-butenedioate(2:1); N-[(S)-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-L-alanine1-methylethylester(2E)-2-butenedioate(2:1); GS-7340(hemifumarate); TENOFOVIR ALAFENAMIDE HEMIFUMARATE(GS-7340 HEMIFUMARATE); Tenofovir levamide aminefumarate; GS7340(Tenofovir Alafenamide Fumarate); (Tenofovir alafenamide:fumarate=2:1) |
| CAS: | 1392275-56-7 |
| MF: | C25H33N6O9P |
| MW: | 592.55 |
| EINECS: | 805-448-8 |
Tenofovir Alafenamide Fumarate Chemical Properties
| Storage temp. | Keep in dark place, Sealed in dry, Room Temperature |
| Solubility | DMSO: 75.0 (maximum concentration in mg/mL); 70.16 (maximum concentration in mM) |
|
Form |
Solid |
|
Color |
White to off-white |
Tenofovir Alafenamide Fumarate Usage
| Uses | Tenofovir alafenamide fumarate (TAF) is an oral nucleoside reverse transcriptase inhibitor developed by Gilead. It is another prodrug of tenofovir disoproxil fumarate (TDF) and is developed for the treatment of hepatitis B virus (HBV) infection and acquired immunodeficiency syndrome (AIDS). |
Hot Tags: Tenofovir Alafenamide Fumarate CAS NO. 1392275-56-7, China, manufacturers, suppliers, factory, custom, wholesale
